European Women Health Diagnostics Market, Industry Trends, Size, Competitive Analysis and Forecast 2019-2025

European women health diagnostics market is growing at a CAGR of approximately 9.1% during the forecast period. According to WHO, there are more than 470 million women living in the European Region, representing just over half of the total population. Understanding women's health is therefore central to understanding the demographic and epidemiological changes, such as aging and migration, occurring in this very diverse Region.

Request a Free Sample of our Report on European Women Health Diagnostics Market: https://www.omrglobal.com/request-sample/european-women-health-diagnostics-market

In addition, according to the World Bank, GDP of Europe region in 2018 was around $ 18.8 trillion, health expenditure remains the second largest item of general government expenditure after expenditure on social protection. The total expenditure of the general government on health amounted to 9.6 % of GDP. This increases healthcare infrastructure, increases the number of clinical laboratories and diagnostic centers, which is expected to push the European women's health diagnostics market during the forecasted year.

Further, lifestyle-related disorders is also growing in Europe, smoking prevalence is lower in women than in men, however, this gap has been closing in recent years due to decreasing numbers of men smoking and increasing numbers of women smoking in certain countries, which may lead to severe problems and diseases, which in turn enhances the growth of the European women health diagnostics market during the forecast period. Cardiovascular diseases continue to comprise a major part of the overall disease burden for women, but rates of mental ill-health are increasing throughout the region and across all ages.

The prominent players operating in the European women health diagnostics market include Immco Diagnostics, Koninklijke Philips NV, Siemens AG, F. Hoffmann-La Roche Ltd., and many others. These players are offering many products for diagnostics and strengthening the European women health diagnostics market value in the forecast year.

A Full Report of European Women Health Diagnostics Market is Available at https://www.omrglobal.com/industry-reports/european-women-health-diagnostics-market

European Women Health Diagnostics Market Segmentation

By Applications
o Breast Cancer Testing
o Cervical Cancer Testing
o Pregnancy & Fertility Testing
o Ovarian Cancer Testing
o Infectious Disease Testing
o Ultrasound Tests
o Sexually Transmitted Disease Testing
o Others (Osteoporosis Testing and Prenatal Genetic Testing)

By End-User
o Diagnostic and Imaging Centers
o Hospitals and Clinics
o Home Care

Regional Analysis
o UK
o Germany
o Italy
o France
o Spain
o Rest of Europe

Company Profiles
o Abbott Laboratories, Inc.
o Becton, Dickson and Co.
o Biomerieux SA
o EKF Diagnostics Holdings PLC
o F. Hoffmann-La Roche Ltd.
o GenMark Diagnostics, Inc.
o Hologic Inc.
o Koninklijke Philips N.V.
o Nova Biomedical Pte. Ltd.
o PerkinElmer Inc.
o QIAGEN N.V.
o Siemens AG
o Thermo Fisher Scientific Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-women-health-diagnostics-market

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.